z-logo
open-access-imgOpen Access
Safety of lamivudine treatment for chronic hepatitis B in early pregnancy
Author(s) -
Wei Yi,
Liu M,
Haodong Cai
Publication year - 2012
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v18.i45.6645
Subject(s) - medicine , lamivudine , pregnancy , obstetrics , hepatitis b virus , adverse effect , abortion , postpartum period , hepatitis b , therapeutic abortion , pediatrics , immunology , virus , biology , genetics
To evaluate the safety of lamivudine (LAM) treatment for chronic hepatitis B in early pregnancy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here